Skip to main content
Erschienen in: Pediatric Rheumatology 1/2013

Open Access 01.11.2013 | Meeting abstract

OR6-003 – Prospective evaluation of PFAPA patients

verfasst von: I Bosio, A Meini, P Cancarini, M Berlucchi, G Savoldi, M Cattalini

Erschienen in: Pediatric Rheumatology | Sonderheft 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

PFAPA (Periodic Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis) is a periodic syndrome described for the first time in 1987 by Marshal et al. In 1999 the diagnostic criteria were formulated by Thomas.

Objectives

all the patients who received a PFAPA diagnosis at our Centre between 1999 and 2012 were prospectively evaluated.

Methods

Sex, age at onset, age at diagnosis, family history, clinical characteristic of the febrile episodes and associated symptoms, prodromes, therapy, therapy response and age at resolution were collected.

Results

In our cohort (148 males and 120 females) fever began at 26.2 + 24 months of age. 8% of the patients had an onset after the fifth year of life, but all other Thomas criteria were met. A family history was present in 39.6 % of patients. Mean duration of PFAPA episodes was 4 + 1.6 days, and a mean interval between episodes 27.9 + 11 days. Most common symptoms with fever were pharyngitis (95.5%), cervical adenitis (63.8%), stomatous aphtosis (38.4%), abdominal pain (32%). Prodromes, such as irritability, nausea and headache were present in 10% of patients. All patients received treatment with oral steroids, using a single administration of 1 mg/kg of prednisone or prednisone equivalent, the first day of fever. In all patients steroids were effective and only 13 % of them experienced a free-interval shortening, without the perceived need to stop the steroids for this reason. There was no difference in the studied parameters between the population who experienced a free-interval shortening and the population in which this event was not registered.
In 144 children resolution occurred, in 58 % of children spontaneously and in 42 % after tonsillectomy. Mean disease duration was 40 + 63 months, medium age at resolution 67.7 + 66 months. Tonsillectomy was efficacious in 60/62 patients. Mutation analysis for FMF, HIDS, and TRAPS in the latter two patients were negative. The tonsillectomy was done after a mean period of 36 months from disease onset.
At multivariate regression analysis disease resolution was independently associated to age onset (β = 1.011 95 %CI 1.000-1.022, p = 0.05) and to tonsillectomy (β = 0.022 95 %CI 0.005-0.092 p = 0.001).

Conclusion

PFAPA is the most common cause of periodic fever in children, however our study confirms that the 5 year of age at disease onset criterion is too strict. Symptoms other than the ones from the classic description, such as abdominal pain, could have clinical relevance. Prodromes are quite common and useful in differentiate the typical PFAPA attack from other episodes of fever. Oral steroids are, in our opinion, the therapy of choice and the free-interval shortening is not perceived as a clinically relevant issue. It is not possible to predict which patients would present this effect. Tonsillectomy is very effective, but should be reserved to a very selected group of patients and with ad adequate period of follow-up before the surgery. Age at onset seems to inversely correlate with disease duration.

Disclosure of interest

None declared
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​ ) applies to the data made available in this article, unless otherwise stated.
Metadaten
Titel
OR6-003 – Prospective evaluation of PFAPA patients
verfasst von
I Bosio
A Meini
P Cancarini
M Berlucchi
G Savoldi
M Cattalini
Publikationsdatum
01.11.2013
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A98

Weitere Artikel der Sonderheft 1/2013

Pediatric Rheumatology 1/2013 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.